NovaBay Pharmaceuticals, Inc.

NBY · AMEX
Analyze with AI
$3.08+$0.28 (+10%)
At close:Dec 15, 2025, 7:20 PM UTC
$3.08+$0.00 (+0%)
After hours:Dec 15, 2025, 7:20 PM UTC
P/E TTM5.39
P/B TTM4.22
P/S TTM3.9
Dividend Yield25.97%
EPS$5.16
Beta0.479
Valuation
PEG Ratio0.04
FCF Yield-39.07%
EV / EBITDA-1.93
More On Valuation »
Quality
ROIC-142.44%
Gross Margin63.20%
Cash Conv. Ratio-2.29
More On Quality »
Growth
Revenue 3Y CAGR-12.10%
FCF Growth-25.04%
More On Growth »
Safety
Net Debt / EBITDA0.58
Interest Coverage-33.32
More On Safety »
Efficiency
Inventory Turnover3.74
Cash Conv. Cycle-28.38
More On Efficiency »

NovaBay Pharmaceuticals, Inc. (NBY) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is NovaBay Pharmaceuticals, Inc. (NBY) stock price today?

As of Dec 15, 2025, 7:20 PM UTC, NovaBay Pharmaceuticals, Inc. (NBY) stock is trading at $3.08. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date NBY stock quotes for informed trading decisions.

What is NovaBay Pharmaceuticals, Inc.'s market capitalization?

NovaBay Pharmaceuticals, Inc. (NBY) has a market capitalization of approximately $18.5M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare NovaBay Pharmaceuticals, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the NBY stock price changes.

What is the 52-week range for NovaBay Pharmaceuticals, Inc. stock?

NovaBay Pharmaceuticals, Inc. (NBY) stock has traded in a 52-week range of $0.46 — $4.44. The 52-week range shows the highest and lowest prices at which NBY traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current NovaBay Pharmaceuticals, Inc. stock price to this range provides context for recent price action.

How much trading volume does NovaBay Pharmaceuticals, Inc. stock have?

NovaBay Pharmaceuticals, Inc. (NBY) stock recently traded approximately 577.6K shares. Trading volume indicates market liquidity and investor interest in NBY. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting NovaBay Pharmaceuticals, Inc. stock.

Does NovaBay Pharmaceuticals, Inc. pay dividends to shareholders?

Yes, NovaBay Pharmaceuticals, Inc. (NBY) currently offers a dividend yield of approximately 25.97%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate NovaBay Pharmaceuticals, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is NovaBay Pharmaceuticals, Inc.'s intraday price range?

Today, NovaBay Pharmaceuticals, Inc. (NBY) stock has traded in a range of $2.70 — $3.20. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring NBY's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get NovaBay Pharmaceuticals, Inc. stock data?

AlphaPilot sources real-time NBY stock quotes, fundamental financial data, and historical price charts for NovaBay Pharmaceuticals, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The NovaBay Pharmaceuticals, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of NBY stock performance.